Literature DB >> 9038684

The relation between Chlamydia pneumoniae and atherosclerosis.

S Gupta, E W Leatham.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9038684      PMCID： PMC484624          DOI： 10.1136/hrt.77.1.7

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  15 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

Review 2.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

3.  Chlamydia pneumonia and meningoencephalitis.

Authors:  M Socan; B Beovic; D Kese
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

4.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; J T Grayston; D S Siscovick; S P Wang; N S Weiss; J R Daling
Journal:  JAMA       Date:  1992-07-01       Impact factor: 56.272

5.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis.

Authors:  Q Xu; J Willeit; M Marosi; R Kleindienst; F Oberhollenzer; S Kiechl; T Stulnig; G Luef; G Wick
Journal:  Lancet       Date:  1993-01-30       Impact factor: 79.321

6.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

7.  Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis.

Authors:  J Braun; S Laitko; J Treharne; U Eggens; P Wu; A Distler; J Sieper
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

8.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

9.  Increased monocyte tissue factor expression in coronary disease.

Authors:  E W Leatham; P M Bath; J A Tooze; A J Camm
Journal:  Br Heart J       Date:  1995-01

10.  Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease.

Authors:  M A Mendall; D Carrington; D Strachan; P Patel; N Molineaux; J Levi; T Toosey; A J Camm; T C Northfield
Journal:  J Infect       Date:  1995-03       Impact factor: 6.072
View more
  2 in total

1.  Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile.

Authors:  L J Murray; D P O'Reilly; G M Ong; C O'Neill; A E Evans; K B Bamford
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

2.  The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection.

Authors:  Kenichi Shimada; Shuang Chen; Paul W Dempsey; Rosalinda Sorrentino; Randa Alsabeh; Anatoly V Slepenkin; Ellena Peterson; Terence M Doherty; David Underhill; Timothy R Crother; Moshe Arditi
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.